Previous 10 | Next 10 |
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Street rating agencies had an overall negative view on Iovance Biotherapeutics ([[IOVA]] -10.6%) with Wells Fargo downgraded to Equal Weight from Overweight ($49 -> $29); Barclays ($45 -> $36) and HC Wainwright ($48 -> $46) lowered the target.While Chardan Capital reaffirmed its...
Gainers: Pioneer Power Solutions (PPSI) +323%.Ocean Power Technologies (OPTT) +82%.Electro-Sensors (ELSE) +30%.Asia Pacific Wire & Cable (APWC) +28%.Alteryx (AYX) +27%.Piedmont Lithium (PLL) +26%.ReneSola (SOL) +25%.TOMI Environmental Solutions (TOMZ) +25%TransAct Technolog...
Gainers: Kiniksa Pharmaceuticals (KNSA) +18%, Humanigen (HGEN) +15%, Neuronetics (STIM) +16%, American Well (AMWL) +13%, Xtant Medical (XTNT) +5%.Losers: Corbus Pharmaceuticals (CRBP) -39%, Axovant Gene Therapies (AXGT)-20%, Iovance Bioth...
Corbus Pharmaceuticals (CRBP) -31% as lenabasum flunks mid-stage cystic fibrosis study.Iovance Biotherapeutics (IOVA) -20% as it has not reached agreement with the FDA on the required potency assays to fully define its tumor-infiltrating lymphocyte therapy lifile...
SAN CARLOS, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today announced that the company plans to present at the following conferences. Jefferies Ce...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. U.S. House hints at Big Tech breakupA House antitrust subcommittee report due this week on big tech - Amazon.com (AMZN), Apple (AAPL), Facebook (FB) and Al...
Gainers: [[AYX]] +27.9%. [[EEX]] +24.1%. [[GLYC]] +15.0%. [[OR]] +8.3%. [[SPAQ]] +4.3%.Losers: [[IOVA]] -22.0%. [[YMAB]] -20.6%. [[KC]] -7.5%. [[DESP]] -4.6%. [[PDI]] -3.9%. For further details see: AYX, EEX, IOVA and YMAB among after-hours movers
Iovance (IOVA) tanks 24% after hours, as it has not reached agreement with the FDA on the required potency assays to fully define its tumor-infiltrating lymphocyte therapy lifileucel in metastatic melanoma.Company is continuing to refine the information from its current potency assa...
SAN CARLOS, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today provided a regulatory update for its tumor-infiltrating lymphocyte (TIL) therapy lifileucel...
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
2024-07-29 05:15:07 ET Piper Sandler analyst issues NEUTRAL recommendation for IOVA on July 29, 2024 02:11AM ET. The previous analyst recommendation was Overweight. IOVA was trading at $9.25 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-07-29 05:00:08 ET Joseph Catanzaro from Piper Sandler issued a price target of $10.00 for IOVA on 2024-07-29 02:11:00. The adjusted price target was set to $10.00. At the time of the announcement, IOVA was trading at $9.25. The overall price target consensus is at $...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...